$ 203.02 <%= Resources.Global.txtUp %>
Updated 19:45:25
Change % 0.12% Stock price increasing
Change 0.245 Stock price increasing
Volume 1,108,308
High $ 204.51
Low $ 200.28
Open $ 203.17
ISIN
Prev close $ 202.77
# of shares 647.27M
Market cap 131,406M USD
Intraday

Amgen Inc
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  203.02 4.7% Stock price increasing 0.3% Stock price increasing 5.3% Stock price increasing 15.9% Stock price increasing 9.0% Stock price increasing
Powered by TradingView

News about Amgen Inc

  • English
  • Regulatory news

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Abbott Laboratories 68,05 -0.5% Stock price decreasing -0.5% Stock price decreasing 5.1% Stock price increasing 14.3% Stock price increasing 22.0% Stock price increasing 19.2% Stock price increasing
 
Bristol-Myers Squibb Company 56.09 -2.5% Stock price decreasing -8.8% Stock price decreasing -1.4% Stock price decreasing 7.2% Stock price increasing -11.9% Stock price decreasing -8.5% Stock price decreasing
 
Johnson & Johnson 138.94 3.8% Stock price increasing -1.1% Stock price decreasing 8.7% Stock price increasing 8.8% Stock price increasing -1.2% Stock price decreasing -0.6% Stock price decreasing
 
Eli Lilly and Company 113,07 4.8% Stock price increasing 5.8% Stock price increasing 25.6% Stock price increasing 41.8% Stock price increasing 31.9% Stock price increasing 33.9% Stock price increasing
 
Merck & Company Inc (new) 71,88 5.1% Stock price increasing 2.1% Stock price increasing 14.2% Stock price increasing 22.0% Stock price increasing 13.2% Stock price increasing 27.7% Stock price increasing
 
Pfizer Inc 43,97 2.7% Stock price increasing 1.1% Stock price increasing 16.8% Stock price increasing 20.5% Stock price increasing 22.7% Stock price increasing 21.4% Stock price increasing
 
Merck Kgaa O.N. 92,64 7.5% Stock price increasing 5.9% Stock price increasing 8.4% Stock price increasing 13.5% Stock price increasing -2.0% Stock price decreasing 3.2% Stock price increasing
 
Novartis NAM SF 0,50 75,00 5.6% Stock price increasing 3.4% Stock price increasing 8.4% Stock price increasing 13.9% Stock price increasing 2.5% Stock price increasing 6.2% Stock price increasing
 
Roche Hldg AG GEN 211,00 3.9% Stock price increasing 0.4% Stock price increasing 5.2% Stock price increasing 16.0% Stock price increasing 0.0% Stock price increasing 0.2% Stock price increasing
 
Glaxosmithkline PLC ORD 25P 1.517,30 4.5% Stock price increasing 2.1% Stock price increasing -3.0% Stock price decreasing 6.7% Stock price increasing -1.1% Stock price decreasing 14.7% Stock price increasing
 
Takeda PHARM.CO.LTD. 36.67 6.2% Stock price increasing 2.7% Stock price increasing 0.8% Stock price increasing -3.3% Stock price decreasing -22.1% Stock price decreasing -21.7% Stock price decreasing
 
Sanofi 77,80 3.2% Stock price increasing 3.9% Stock price increasing 7.3% Stock price increasing 18.2% Stock price increasing -7.9% Stock price decreasing 8.3% Stock price increasing
 
Biogen Inc 330.41 1.0% Stock price increasing -1.9% Stock price decreasing -7.8% Stock price decreasing 23.3% Stock price increasing -4.1% Stock price decreasing 3.7% Stock price increasing
 
Bayer AG NA O.N. 78,42 1.4% Stock price increasing 7.0% Stock price increasing -15.6% Stock price decreasing -21.8% Stock price decreasing -34.0% Stock price decreasing -24.6% Stock price decreasing
 
Teva Pharmaceutical Industries.. 21.32 4.3% Stock price increasing -12.8% Stock price decreasing -9.4% Stock price decreasing 19.0% Stock price increasing 45.8% Stock price increasing 12.5% Stock price increasing

Company profile

Amgen Inc is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix and received approval for bone-strengthening drug Prolia/Xgeva.

Peers

Instruments Last Change  
Abbott Labor.. 68,05 -3.1% Stock price decreasing
Bristol-Myer.. 56.09 -4.8% Stock price decreasing
Johnson & Jo.. 138.94 -0.4% Stock price decreasing
Eli Lilly an.. 113,07 -0.5% Stock price decreasing
Merck & Comp.. 71,88 0.1% Stock price increasing
Pfizer Inc 43,97 -1.3% Stock price decreasing
Merck Kgaa O.. 92,64 0.4% Stock price increasing
Novartis NAM.. 75,00 1.8% Stock price increasing
Roche Hldg A.. 211,00 2.6% Stock price increasing
Glaxosmithkl.. 1.517,30 1.5% Stock price increasing
Takeda PHARM.. 36.67 4.0% Stock price increasing
17,17,17,0,0,0,100,100,100,100
Sanofi 77,80 0.8% Stock price increasing
Biogen Inc 330.41 -2.3% Stock price decreasing
100,85,68,36,16,37,8,5,22,27
Bayer AG NA .. 78,42 1.3% Stock price increasing
Teva Pharmac.. 21.32 0.6% Stock price increasing

Copyright Berlingske Media 2018  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
18 October 2018 20:00:51
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20181005.3 - EUROWEB6 - 2018-10-18 21:00:51 - 2018-10-18 20:00:51 - 1000 - Website: OKAY